Literature DB >> 16015120

Neuromuscular sequelae of critical illness.

Nicola Latronico1, Indrit Shehu, Elisa Seghelini.   

Abstract

PURPOSE OF REVIEW: To investigate the impact of critical illness polyneuropathy and critical illness myopathy on short-term and long-term patient outcome. RECENT
FINDINGS: In the acute-care setting, critical illness polyneuropathy and critical illness myopathy are important causes of acute paralysis in critically ill comatose patients, and may cause inappropriately pessimistic prognoses. Duration of weaning from artificial ventilation is 2 to 7 times greater in patients with critical illness polyneuropathy than in patients without critical illness polyneuropathy. After intensive care unit and hospital discharge, many patients diagnosed with critical illness polyneuropathy or critical illness myopathy are reported to complain of profound muscle weakness. Chronic disability was a common finding among them. Complete functional recovery with patients regaining the ability to breathe spontaneously and to walk independently was reported in 180 of 263 patients (68.4%); severe disability with tetraparesis, tetraplegia, or paraplegia was reported in 74 patients (28.1%). Persisting milder disabilities were common even in patients with complete functional recovery, and included reduced or absent deep tendon reflexes, stocking and glove sensory loss, muscle atrophy, painful hyperesthesia, and foot drop. An association of critical illness polyneuropathy and critical illness myopathy with increased intensive care unit and hospital mortality has been demonstrated only in selected intensive care unit populations; data are insufficient to demonstrate any association with long-term mortality.
SUMMARY: Intensive care unit-acquired critical illness polyneuropathy and critical illness myopathy influence the evaluation of acutely ill comatose patients and may instigate unreasonably pessimistic prognosis. Critical illness polyneuropathy and critical illness myopathy are an important cause of difficult weaning of patients from the ventilator and of persisting muscle weakness and disability after intensive care unit discharge.

Entities:  

Mesh:

Year:  2005        PMID: 16015120     DOI: 10.1097/01.ccx.0000168530.30702.3e

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  47 in total

1.  Physical therapy management and patient outcomes following ICU-acquired weakness: a case series.

Authors:  Amy Nordon-Craft; Margaret Schenkman; Kyle Ridgeway; Alexander Benson; Marc Moss
Journal:  J Neurol Phys Ther       Date:  2011-09       Impact factor: 3.649

Review 2.  Intensive care unit-acquired weakness: implications for physical therapist management.

Authors:  Amy Nordon-Craft; Marc Moss; Dianna Quan; Margaret Schenkman
Journal:  Phys Ther       Date:  2012-01-26

3.  Suxamethonium in the intensive care unit: "Fool me once, shame on you; fool me twice, shame on me".

Authors:  Hannah Church; Sue Sinclair; Tessa Oelofse
Journal:  Intensive Care Med       Date:  2007-10-18       Impact factor: 17.440

4.  Critical illness polyneuropathy following childhood appendicitis.

Authors:  D Mullassery; A Curran; P D Losty
Journal:  Pediatr Surg Int       Date:  2008-07-30       Impact factor: 1.827

5.  A Randomized Trial of an Intensive Physical Therapy Program for Patients with Acute Respiratory Failure.

Authors:  Marc Moss; Amy Nordon-Craft; Dan Malone; David Van Pelt; Stephen K Frankel; Mary Laird Warner; Wendy Kriekels; Monica McNulty; Diane L Fairclough; Margaret Schenkman
Journal:  Am J Respir Crit Care Med       Date:  2016-05-15       Impact factor: 21.405

Review 6.  Critical illness polyneuropathy and myopathy in the intensive care unit.

Authors:  Wolfgang Zink; Rainer Kollmar; Stefan Schwab
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

Review 7.  Quantitative neuromuscular ultrasound in intensive care unit-acquired weakness: A systematic review.

Authors:  Aaron Bunnell; John Ney; Alfred Gellhorn; Catherine L Hough
Journal:  Muscle Nerve       Date:  2015-09-21       Impact factor: 3.217

8.  IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy?

Authors:  Oliver Friedrich; Bing Yi; Joshua N Edwards; Barbara Reischl; Anette Wirth-Hücking; Andreas Buttgereit; Roland Lang; Cornelia Weber; Fabian Polyak; Ilon Liu; Frederic von Wegner; Tanya R Cully; Aven Lee; Patrick Most; Mirko Völkers
Journal:  Am J Respir Cell Mol Biol       Date:  2014-06       Impact factor: 6.914

Review 9.  Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.

Authors:  Efstratios Apostolakis; Nikolaos A Papakonstantinou; Nikolaos G Baikoussis; George Papadopoulos
Journal:  J Anesth       Date:  2014-07-01       Impact factor: 2.078

10.  Role of endotoxin in the pathogenesis of critical illness polyneuropathy.

Authors:  B Mohammadi; I Schedel; K Graf; A Teiwes; H Hecker; B Haameijer; D Scheinichen; S Piepenbrock; R Dengler; J Bufler
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.